Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 492

1.

Multi-Biomarker Analysis in Patients with Acute Myocardial Infarction.

Schernthaner C, Lichtenauer M, Wernly B, Paar V, Pistulli R, Rohm I, Jung C, Figulla HR, Yilmaz A, Cadamuro J, Haschke-Becher E, Pernow J, Schulze PC, Hoppe UC, Kretzschmar D.

Eur J Clin Invest. 2017 Jul 6. doi: 10.1111/eci.12785. [Epub ahead of print]

PMID:
28683166
2.

Acute effects of moderate altitude on biomarkers of cardiovascular inflammation and endothelial function and their differential modulation by dual endothelin receptor blockade.

Lichtenauer M, Goebel B, Paar V, Wernly B, Gecks T, Rohm I, Förster M, Betge S, Figulla HR, Hoppe UC, Kelm M, Franz M, Jung C.

Clin Hemorheol Microcirc. 2017 May 24. doi: 10.3233/CH-170273. [Epub ahead of print]

PMID:
28550241
3.

Vena contracta area for severity grading in functional and degenerative mitral regurgitation: a transoesophageal 3D colour Doppler analysis in 500 patients.

Goebel B, Heck R, Hamadanchi A, Otto S, Doenst T, Jung C, Lauten A, Figulla HR, Schulze PC, Poerner TC.

Eur Heart J Cardiovasc Imaging. 2017 Apr 21. doi: 10.1093/ehjci/jex056. [Epub ahead of print]

PMID:
28444164
4.

Endothelial progenitor cells and plaque burden in stented coronary artery segments: an optical coherence tomography study six months after elective PCI.

Otto S, Nitsche K, Jung C, Kryvanos A, Zhylka A, Heitkamp K, Gutiérrez-Chico JL, Goebel B, Schulze PC, Figulla HR, Poerner TC.

BMC Cardiovasc Disord. 2017 Apr 26;17(1):103. doi: 10.1186/s12872-017-0534-1.

5.

Soluble ST2 predicts 1-year outcome in patients undergoing transcatheter aortic valve implantation.

Wernly B, Lichtenauer M, Jirak P, Eder S, Reiter C, Kammler J, Kypta A, Jung C, Franz M, Hoppe UC, Landmesser U, Figulla HR, Lauten A.

Eur J Clin Invest. 2017 Feb;47(2):149-157. doi: 10.1111/eci.12719.

PMID:
28036122
6.

Quality of Life After Transcatheter Aortic Valve Replacement: Prospective Data From GARY (German Aortic Valve Registry).

Lange R, Beckmann A, Neumann T, Krane M, Deutsch MA, Landwehr S, Kötting J, Welz A, Zahn R, Cremer J, Figulla HR, Schuler G, Holzhey DM, Funkat AK, Heusch G, Sack S, Pasic M, Meinertz T, Walther T, Kuck KH, Beyersdorf F, Böhm M, Möllmann H, Hamm CW, Mohr FW; GARY Executive Board.

JACC Cardiovasc Interv. 2016 Dec 26;9(24):2541-2554. doi: 10.1016/j.jcin.2016.09.050.

PMID:
28007203
7.

Interventional left atrial appendage occlusion: added value of 3D transesophageal echocardiography for device sizing.

Goebel B, Wieg S, Hamadanchi A, Otto S, Jung C, Kretzschmar D, Figulla HR, Christian Schulze P, Poerner TC.

Int J Cardiovasc Imaging. 2016 Sep;32(9):1363-1370. Epub 2016 Jun 6.

PMID:
27271934
8.

Transcatheter interventions for tricuspid regurgitation - heterotopic technology: TricValve.

Figulla HR, Kiss K, Lauten A.

EuroIntervention. 2016 Sep 18;12(Y):Y116-8. doi: 10.4244/EIJV12SYA32. No abstract available.

9.

Detection of Soluble ED-A(+) Fibronectin and Evaluation as Novel Serum Biomarker for Cardiac Tissue Remodeling.

Ziffels B, Ospel J, Grün K, Neri D, Pfeil A, Fritzenwanger M, Figulla HR, Jung C, Berndt A, Franz M.

Dis Markers. 2016;2016:3695454. doi: 10.1155/2016/3695454. Epub 2016 Aug 18.

10.

A novel polymer-free ciglitazone-coated vascular stent: in vivo and ex vivo analysis of stent endothelialization in a rabbit iliac artery model.

Otto S, Jaeger K, Kolodgie FD, Muehlstaedt D, Franz M, Bischoff S, Schubert H, Figulla HR, Virmani R, Poerner TC.

Oncotarget. 2016 Sep 6;7(36):57571-57580. doi: 10.18632/oncotarget.11584.

11.

Alterations in systemic levels of Th1, Th2, and Th17 cytokines in overweight adolescents and obese mice.

Jung C, Lichtenauer M, Strodthoff D, Winkels H, Wernly B, Bürger C, Kamchybekov U, Lutgens E, Figulla HR, Gerdes N.

Pediatr Diabetes. 2016 Sep 6. doi: 10.1111/pedi.12435. [Epub ahead of print]

PMID:
27597513
12.

Resistant hypertension: Comparison of unifocal versus multifocal radiofrequency ablation for renal denervation up to 24months follow-up.

Prochnau D, Schweizer C, Hoyme M, Figulla HR, Schulze PC, Surber R.

Int J Cardiol. 2016 Nov 15;223:31-33. doi: 10.1016/j.ijcard.2016.08.192. Epub 2016 Aug 9. No abstract available.

PMID:
27529585
13.

Pulse contour cardiac output monitoring in acute heart failure patients : Assessment of hemodynamic measurements.

Wernly B, Lichtenauer M, Franz M, Fritzenwanger M, Kabisch B, Figulla HR, Jung C.

Wien Klin Wochenschr. 2016 Dec;128(23-24):864-869. Epub 2016 Aug 15.

14.

Microparticles in patients undergoing transcatheter aortic valve implantation (TAVI).

Jung C, Lichtenauer M, Figulla HR, Wernly B, Goebel B, Foerster M, Edlinger C, Lauten A.

Heart Vessels. 2017 Apr;32(4):458-466. doi: 10.1007/s00380-016-0885-z. Epub 2016 Aug 3.

15.

Noncoronary Measures Enhance the Predictive Value of Cardiac CT Above Traditional Risk Factors and CAC Score in the General Population.

Mahabadi AA, Lehmann N, Möhlenkamp S, Pundt N, Dykun I, Roggenbuck U, Moebus S, Jöckel KH, Erbel R, Kälsch H; Heinz Nixdorf Investigative Group.

JACC Cardiovasc Imaging. 2016 Oct;9(10):1177-1185. doi: 10.1016/j.jcmg.2015.12.024. Epub 2016 Jul 20.

PMID:
27450878
16.

Predictive value of the augmentation index derived vascular age in patients with newly diagnosed atherosclerosis.

Betge S, Kretzschmar D, Figulla HR, Lichtenauer M, Jung C.

Heart Vessels. 2017 Mar;32(3):252-259. doi: 10.1007/s00380-016-0868-0. Epub 2016 Jul 11.

17.

Fractional flow reserve-guided coronary angioplasty using paclitaxel-coated balloons without stent implantation: feasibility, safety and 6-month results by angiography and optical coherence tomography.

Poerner TC, Duderstadt C, Goebel B, Kretzschmar D, Figulla HR, Otto S.

Clin Res Cardiol. 2017 Jan;106(1):18-27. doi: 10.1007/s00392-016-1019-4. Epub 2016 Jul 5.

18.

Effect of endothelin-1 and endothelin receptor blockade on the release of microparticles.

Jung C, Lichtenauer M, Wernly B, Franz M, Goebel B, Rafnsson A, Figulla HR, Pernow J.

Eur J Clin Invest. 2016 Aug;46(8):707-13. doi: 10.1111/eci.12652. Epub 2016 Jul 11.

PMID:
27322814
19.

Renal denervation with standard radiofrequency ablation catheter is effective in 24-hour ambulatory blood pressure reduction - follow-up at 1/3/6/12 months.

Prochnau D, Otto S, Figulla HR, Surber R.

Neth Heart J. 2016 Jul;24(7-8):449-55. doi: 10.1007/s12471-016-0839-1.

20.

The transcatheter valve technology pipeline for treatment of adult valvular heart disease.

Figulla HR, Webb JG, Lauten A, Feldman T.

Eur Heart J. 2016 Jul 21;37(28):2226-39. doi: 10.1093/eurheartj/ehw153. Epub 2016 May 8. Review.

PMID:
27161617

Supplemental Content

Loading ...
Support Center